title: Limited Access to New Hepatitis C Virus Treatment Under State Medicaid Programs.
authors.forename: Lauren A
authors.initials: LA
authors.lastname: Canary
authors.forename: R Monina
authors.initials: RM
authors.lastname: Klevens
authors.forename: Scott D
authors.initials: SD
authors.lastname: Holmberg
mesh_terms: D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use*; D002017:Budgets; D016527:Drug Costs; D004608:Eligibility Determination; D006291:Health Policy; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007349:Insurance, Health, Reimbursement; D008484:Medicaid / Q000191:economics*; D000069474:Sofosbuvir; D014481:United States; D014542:Uridine Monophosphate / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D014542:Uridine Monophosphate; D000069474:Sofosbuvir